Eric Crombez, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Crombez, M.D.
Eric Crombez, M.D. is recorded as CTO at Ultragenyx Pharmaceutical Inc. (RARE). Ultragenyx Pharmaceutical Inc. reported in an 8-K filed March 14, 2023 that Eric Crombez, M.D. was appointed Executive Vice President, Chief Medical Officer, effective May 1, 2023. Eric Crombez, M.D. has spoken on 1 earnings call across 1 company, most recently for Ultragenyx Pharmaceutical Inc. on May 5, 2026.
“Eric Crombez, M.D., the Company's current Chief Medical Officer for Gene Therapy and Inborn Errors of Metabolism, will assume the role of Executive Vice President, Chief Medical Officer, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-01–present
-
Current
2023-05-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ultragenyx Pharmaceutical Inc.
Other people whose current roles at this company are on record from its filings.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Karah Parschauer General Counsel
- Amrit Ray, M.D. Board Member
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
- Daniel G. Welch Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.